ATLANTA, GA -- The 2023 Rx and Illicit Drug Summit featured a congressional panel on day two of the 12th annual conference led by U.S. Rep. Hal Rogers (KY-05), Dean of the House, who launched the national summit to help combat America's deadly epidemic. Congressman Rogers was joined by Reps. Earl L. "Buddy" Carter (R-GA), David Trone (D-MD), Matt Cartwright (D-PA), and Andrew Clyde… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Henry Cuellar (D-TX), and Chairman of the Select Committee on the Strategic Competition Between the United States and the Chinese Communist Party Mike Gallagher (R-WI) today introduced the bipartisan Pausing Enhanced Pandemic Pathogen Research Act to ban taxpayer dollars from funding gain-of-function research for five years, allowing… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) successfully lobbied the Food and Drug Administration (FDA) today to increase access to Emergent Biosolution’s life-saving opioid overdose reversal nasal spray, sold under the brand name Narcan, for use without a prescription.
Naloxone nasal spray is a safe, easy to use treatment that is proven “to reduce medical emergencies, drug… Read more »
WASHINGTON, D.C. - Reps. Earl L. “Buddy” Carter (R-GA), Elissa Slotkin (D-MI), Chrissy Houlahan (D-PA), and Gus Bilirakis (R-FL) officially launched the bipartisan Domestic Pharmaceutical Manufacturing Caucus for the 118th Congress.
The caucus will focus on advancing legislation that incentivizes more domestic production for essential medicines to reduce… Read more »
WASHINGTON, D.C. - Rep. Earl L. “Buddy” Carter (R-GA), Rep. Vicente Gonzalez (D-TX), House Republican Conference Chair Rep. Elise Stefanik (R-NY), Rep. Deborah Ross (D-NC), Rep. Rick Allen (R-GA), and Rep. Jake Auchincloss (D-MA) today introduced bipartisan legislation to end spread pricing in Medicaid programs, which leads to low reimbursement rates for pharmacies and artificially raises… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Yvette Clarke (D-NY), and Pete Sessions (R-TX) this week introduced the bipartisan Dental and Optometric Care Access (DOC Access) Act to provide fairness in contracts between health care providers and vision and dental insurers, thereby increasing the quality of care for patients and eliminating anti-competitive practices.
Current… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Bruce Westerman (R-AR), Jared Golden (D-ME), and Dutch Ruppersberger (D-MD) introduced the Patients’ Right to Know Their Medication Act of 2023 to ensure that rural Americans and seniors have access to important information about their prescription medications and to protect the jobs of hardworking Georgians.
It is common… Read more »
WASHINGTON, D.C. –Reps. Earl L. “Buddy” Carter (R-GA) and Mariannette Miller-Meeks (R-IA) sent a letter to Food and Drug Administration (FDA) Commissioner Robert Califf calling for the FDA to make naloxone, an overdose reversal drug, available without a prescription.
Our current fentanyl crisis has already killed more than 71,000 people, with tens of thousands of additional lives saved… Read more »
WASHINGTON, D.C. – Reps. Earl L. “Buddy” Carter (R-GA), Nanette Barragán (D-CA), Miller-Meeks (R-IA), and Diana DeGette (D-CO) this week introduced the Help Ensure Lower Patient (HELP) Copays Act to protect patients from harmful insurance and pharmacy benefit manager practices that raise patient out-of-pocket drug costs.
The bipartisan HELP Copays Act would prohibit the use of “copay… Read more »
WASHINGTON, D.C. – Rep. Earl L. “Buddy” Carter (R-GA) today introduced the Fairness in Orphan Drug Exclusivity Act, a bill to close a loophole that allows drug manufacturers to block new treatments options for rare diseases from coming to the market.
The Fairness in Orphan Drug Exclusivity Act amends the Orphan Drug Act of 1983 to require all drugs that obtain seven-years of… Read more »
